Sarah Gheuens, Chief Medical Officer: Agios Pharmaceuticals AGIO Sell · Filed 24/01/24

Trade details

Type: Insider sale
Amount: $36,961.12
Shares · price: 1,708 sh · $21.64 a share
Held after: 31,911 sh
Stock: Agios Pharmaceuticals AGIO
Person: Sarah GheuensChief Medical Officer
Trade date: 24/01/24
Filed: 24/01/24
Days to filing: 0 days

Sold 5.1% of holdings

Share of holding sold: 5.1%

Agios Pharmaceuticals trades, last 26 weeks

What else happened in Agios Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/12/25~24/02/23

Sarah Gheuens's recent trades

Sarah GheuensChief Medical Officer
Planned sale10b5-1 planAgios Pharmaceuticals
Planned sale10b5-1 plan
Agios Pharmaceuticals
AGIO
$914.3K
30,000 sh
$914.3K
Filed 08/04
Traded 08/04
Sarah GheuensChief Medical Officer
Planned sale10b5-1 planAgios Pharmaceuticals
Planned sale10b5-1 plan
Agios Pharmaceuticals
AGIO
$150.5K
4,007 sh
$150.5K
Filed 07/01
Traded 07/01
Sarah GheuensChief Medical Officer
Sell10b5-1 planAgios Pharmaceuticals
Sell10b5-1 plan
Agios Pharmaceuticals
AGIO
$102K
2,940 sh
$102K
Filed 04/06
Traded 04/02
Sarah GheuensChief Medical Officer
Planned sale10b5-1 planAgios Pharmaceuticals
Planned sale10b5-1 plan
Agios Pharmaceuticals
AGIO
$100.5K
2,940 sh
$100.5K
Filed 04/02
Traded 04/02
Sarah GheuensChief Medical Officer
Sell10b5-1 planAgios Pharmaceuticals
Sell10b5-1 plan
Agios Pharmaceuticals
AGIO
$48.7K
1,681 sh
$48.7K
Filed 03/03
Traded 03/02

Sarah Gheuens, Chief Officer — sold $37K of Agios Pharmaceuticals AGIO · 5.1% of holdings · 10b5-1 plan | Whalegun